Cambridge, United Kingdom

Azim M Surani

This inventor holds 1 USPTO granted patent. Top assignees: Medical Research Council, The Babraham Institute. Active years: 1996.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1,466(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Azim M Surani: Innovator in Antibody Production

Introduction

Azim M Surani is a prominent inventor based in Cambridge, GB. He is known for his significant contributions to the field of immunology, particularly in the production of antibodies from transgenic animals. His innovative work has paved the way for advancements in therapeutic applications and research.

Latest Patents

Surani holds a patent for the "Production of antibodies from transgenic animals." This patent describes a method for obtaining chimaeric or wholly foreign immunoglobulin from cells or body fluids of a transgenic animal. The animal has had genetic material inserted into its germline that encodes for at least part of an immunoglobulin of foreign origin. This process allows for the production of wholly human immunoglobulins from a transgenic mouse, which can respond to introduced immunogens.

Career Highlights

Throughout his career, Azim M Surani has worked with esteemed institutions such as the Babraham Institute and the Medical Research Council. His research has significantly impacted the understanding of antibody production and its applications in medicine.

Collaborations

Surani has collaborated with notable colleagues, including Marianne Bruggemann and Michael S Neuberger. These partnerships have contributed to the advancement of research in immunology and biotechnology.

Conclusion

Azim M Surani's innovative work in antibody production from transgenic animals highlights his role as a key figure in the field of immunology. His contributions continue to influence research and therapeutic developments in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…